Autres langues Cytek Biosciences, Inc.

Actions

CTKB

US23285D1090

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/06/2024			Varia. 5j.	Varia. 1 janv.
6 ^USD	+0,50 %		+6,57 %	-34,21 %

06/06	Le conseil d'administration de Cytek Biosciences approuve un plan de rachat d'actions de 50 millions de dollars	MT
06/06	Cytek Biosciences, Inc. (NasdaqGS:CTKB) annonce un rachat d'actions pour une valeur de 50 millions de dollars.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cytek Biosciences Board Approves $50 Million Share Buyback Plan	06/06
Cytek Biosciences Announces $50 Million Stock Repurchase Program	06/06
Cytek Biosciences Announces $50 Million Stock Repurchase Program	06/06
Cytek Biosciences, Inc. announces an Equity Buyback for $50 million worth of its shares.	06/06
Cytek Biosciences, Inc. authorizes a Buyback Plan.	06/06
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference	30/05
Sector Update: Health Care Stocks Lean Lower Premarket Wednesday	29/05
Cytek Biosciences Gets Approval for Clinical Use of TBNK Reagents in China	29/05
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China	28/05
Cytek Biosciences : ® Biosciences Adds Ability to Detect Subcellular Par ...	21/05
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems	20/05
Cytek Biosciences, Inc. Adds Ability to Detect Subcellular Particles to Its Cell Analysis Systems	20/05
Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 Revenue $44.9M, vs. Street Est of $43.6M	08/05
Cytek Biosciences Reports First Quarter 2024 Financial Results	08/05
Cytek Biosciences, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024	08/05
Cytek Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe	30/04
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024	29/04
Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing	20/03
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance	19/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cytek Biosciences, Inc.

Actions

CTKB

US23285D1090

Autres langues

Filtres